Company Number: 14431441

Analysis Date: 2025-07-29 13:32 UTC

1. Industry Classification
   NeuroExpt Limited operates under SIC code 86220, classified as "Specialists medical practice activities." This sector encompasses specialised medical services typically provided by healthcare professionals with advanced expertise, such as specialists in neurology, cardiology, or other focused clinical fields. Characteristics of this sector include reliance on professional qualifications, adherence to healthcare regulations, and a service-driven business model. Providers often serve niche patient groups or referral networks and may engage in diagnostic, therapeutic, or consultative services.

2. Relative Performance
   As a private limited company incorporated in late 2022, NeuroExpt Limited is in its early growth stage. The latest financials for the year ended October 2024 show net assets of £31,768, up from £4,005 in 2023, indicating a significant strengthening of the balance sheet and working capital (net current assets increased from £4,005 to £31,253). The company holds modest tangible fixed assets (£515) and current assets primarily comprised of cash (£36,182) and trade debtors (£7,321). Given its small size—evidenced by 2 employees (the directors)—and small company reporting exemptions, it is classified as a micro-entity or small business within the healthcare specialist sector.

Compared to typical industry metrics, specialist medical practices often exhibit higher revenue turnover and asset bases once established due to patient volumes, equipment investments, and staff. NeuroExpt’s balance sheet and asset size are consistent with a very early-stage or niche entrant still building its client base and operational scale. Its current liabilities (notably corporation tax of £10,498) are elevated relative to size but manageable given cash reserves, signaling prudent liquidity management.

3. Sector Trends Impact
   The specialist medical practice sector is influenced by several macro and micro trends: increasing demand for specialised outpatient services due to ageing populations and chronic disease prevalence; growing integration of technology and telemedicine; regulatory pressures on compliance and data security; and shifts in funding models including NHS contracts and private insurance reimbursements.

For a newly established company like NeuroExpt, these trends present both challenges and opportunities. The rising demand for specialist care can drive growth, but competition is intense, requiring differentiation via clinical expertise, innovation, or niche focus. Additionally, regulatory compliance costs and the need for continuous professional development may impose financial and operational burdens initially. The company’s small scale and recent founding limit its immediate ability to leverage economies of scale or invest heavily in advanced medical technology.

4. Competitive Positioning
   NeuroExpt Limited is currently a niche player within the specialist medical practice sector. Its competitive strengths likely lie in the professional expertise of its directors—one noted as a doctor and the other as an architect, indicating a potentially multidisciplinary approach or complementary skill sets supporting the medical business. The company’s strong liquidity position and positive net asset growth in its first two years show sound financial stewardship.

However, compared to established competitors—often larger clinics, hospital-affiliated specialists, or multi-specialty groups—NeuroExpt lacks scale, brand recognition, and diversified service lines. Its limited fixed assets and workforce constrain throughput capacity and service range. The company must focus on building referral relationships, maintaining high clinical standards, and possibly leveraging digital platforms to enhance patient engagement and operational efficiency.

Executive Summary